6655:HKEXHuaxin Building Materials Group Co Ltd Class H Analysis
Data as of 2026-03-16 - not real-time
HK$16.45
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Huaxin Building Materials is trading at HK$16.45, just above its near‑term support of HK$16.15 and well below the computed fair value of HK$18.99, indicating a sizable upside potential. The technical picture is mixed: the 14‑day RSI sits at 37, hinting at slight oversold conditions, while the MACD remains bearish and the 20‑day SMA (HK$17.54) is still above the current price, suggesting continued pressure. However, volume is on an increasing trend and the broader market sentiment is in a “Greed” phase, which could provide short‑term buying momentum.
Fundamentally, the stock appears attractively priced with a trailing PE of 9.6x, a PB of 0.94x, and a dividend yield of 5.2% supported by a modest 30% payout ratio. The DCF model projects a fair value of nearly HK$19, implying roughly 35% upside, while revenue growth of 5.9% and solid operating margins underscore a stable earnings base. Nevertheless, the company carries high leverage (debt‑to‑equity ~69) and negative free cash flow, which temper the upside and highlight the need for careful monitoring of cash generation.
Fundamentally, the stock appears attractively priced with a trailing PE of 9.6x, a PB of 0.94x, and a dividend yield of 5.2% supported by a modest 30% payout ratio. The DCF model projects a fair value of nearly HK$19, implying roughly 35% upside, while revenue growth of 5.9% and solid operating margins underscore a stable earnings base. Nevertheless, the company carries high leverage (debt‑to‑equity ~69) and negative free cash flow, which temper the upside and highlight the need for careful monitoring of cash generation.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near support with limited downside
- Increasing volume despite bearish MACD
- High dividend yield provides cushion
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Valuation gap to DCF fair value (~35% upside)
- Low PE and PB relative to peers
- Sustainable dividend and modest payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term upside to fair value and stable earnings growth
- Defensive beta (0.13) and strong dividend yield
- Potential for deleveraging and cash‑flow improvement
Key Metrics & Analysis
Financial Health
Revenue Growth5.90%
Profit Margin9.50%
P/E Ratio9.6
ROE11.06%
ROA4.45%
Debt/Equity69.16
P/B Ratio0.9
Op. Cash FlowHK$5.8B
Free Cash FlowHK$-3035956736
Technical Analysis
TrendNeutral
RSI37.3
SupportHK$16.15
ResistanceHK$18.98
MA 20HK$17.54
MA 50HK$18.30
MA 200HK$15.10
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueHK$18.99
Target PriceHK$22.25
Upside/Downside35.26%
GradeUndervalued
TypeBlend
Dividend Yield5.20%
Risk Assessment
Beta0.13
Volatility45.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.